New nanoparticles target cardiovascular disease

Researchers at MIT and Harvard Medical School have built targeted nanoparticles that can cling to artery walls and slowly release medicine, an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.

Read the whole article on Physorg

More from Physorg